CFA
IRWD icon

Carroll Financial Associates’s Ironwood Pharmaceuticals IRWD Stock Holding History

Carroll Financial Associates’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-252
Closed -$3K – 1772
2021
Q3 		$3K Sell
252
-14,592
-98% -$189K ﹤0.01% 1482
2021
Q2 		$191K Buy
+14,844
New +$170K 0.01% 423
2014
Q3 		– Sell
-1,194
Closed -$15K – 881
2014
Q2 		$15K Hold
1,194
– – ﹤0.01% 525
2014
Q1 		$12K Hold
1,194
– – ﹤0.01% 502
2013
Q4 		$11K Buy
+1,194
New +$10.7K ﹤0.01% 495

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Carroll Financial Associates's IRWD Position: Q4 2021 in Review

Carroll Financial Associates sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2021, closing a stake of 252 shares — an estimated $3K sold.

Carroll Financial Associates first reported a position in IRWD in Q4 2013 and held it in 5 quarters. The position peaked at $191K in Q2 2021. 212 funds tracked by Wall St. Rank hold IRWD as of Q4 2021.

  • Carroll Financial Associates reported no remaining Ironwood Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Carroll Financial Associates sold 252 Ironwood Pharmaceuticals shares in Q4 2021, an estimated $3K.
  • Carroll Financial Associates first reported a position in Ironwood Pharmaceuticals in Q4 2013 and held it in 5 quarters.
  • Carroll Financial Associates's Ironwood Pharmaceuticals position peaked at $191K in Q2 2021.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2021.

Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.